Parker Waichman LLP

Eli Lilly’s Experimental Lung Cancer Drug May Increase Risk of Blood Clots

In a report issued Tuesday, the U.S. Food and Drug Administration (FDA) raised concerns that Eli Lilly’s experimental lung cancer drug necitumumab could increase the likelihood of blood clots. The agency found that the drug was associated with a greater chance of overall survival, but that it may also present a higher risk of life-threatening […]

Eli Lilly’s Lung Cancer Drug Increases Risk of Blood Clots

Eli Lilly’s Lung Cancer Drug Increases Risk of Blood Clots

In a report issued Tuesday, the U.S. Food and Drug Administration (FDA) raised concerns that Eli Lilly’s experimental lung cancer drug necitumumab could increase the likelihood of blood clots. The agency found that the drug was associated with a greater chance of overall survival, but that it may also present a higher risk of life-threatening blood clots. Eli Lilly wants to sell the drug as a form of treatment for patients with advanced squamous non-small cell lung cancer, a subset of the most common form of lung cancer, in combination with chemotherapy.

According to Bloomberg, FDA advisers will weigh the pros and cons of the drug on Thursday. A decision on whether not the drug can be sold is expected by the end of the year. FDA staff said in the report that the risk of clotting “in this already high risk population is of concern,” although the safety of necitumumab is on par with similar medications.

The report pointed to one study showing that 9 percent of 538 patients taking necitumumab with chemotherapy suffered from a blood clot. In comparison, 5 percent of 541 patients given chemotherapy only suffered from a blood clot. The FDA report also cited a clinical trial where patients taking the drug lived 1.6 months longer than those receiving chemotherapy only; necitumumab users lived a median of 11.5 months.

According to the American Cancer Society, squamous lung cancer comprises 25 to 30 percent of all lung cancer. Analysts predict that necitumumab will generate $567 million in sales in 2020. The drug would be used as a initial treatment in combination with chemotherapy, unlike Lily’s current non-small cell lung cancer drug Cyramza, which is used for patients whose cancer is worsening despite chemotherapy.

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
My name is Yolanda. When I sat down with them they treated me like family. I had Alex and Cathy. As long as I had them I still don't know Cathy's last name. They showed compassion and understanding. The young ladies in the front always had a smile. How I knew I had the right Law Firm is whenever I came to the office they knew my name. That meant EVERYTHING to me. Thank you for your kindness and love.
big lan
a year ago
5 Star Reviews 150
Positive: Professionalism , Quality , Responsiveness , Value
Edith Barrow
2 years ago
5 Star Reviews 150
Positive: Professionalism I would like to give Christina(Tina)Morace a (5)five stars review,Christina is a very pleasant person, her client professional skills are excellent, very informative,always available to answer my questions and quick to return calls.it was a pleasure communicant with Christina Morace.thank you very much
sandra benejan
2 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038